自引率: 2.8%
被引量: 11488
通过率: 暂无数据
审稿周期: 1.69
版面费用: 暂无数据
国人发稿量: 134
投稿须知/期刊简介:
Molecular Immunology is primarily devoted to the publication of immunological knowledge which can be delineated at the molecular level. Within this framework are included contributions concerned with the molecular analysis of the cellular components and processes which underlie the physiological behavior of cells involved in immune phenomena. Papers which merely describe new monoclonal antibodies and/or epitope mapping will no longer be accepted unless they have a direct relevance to the understanding of the immune system. The various forms of communications in Molecular Immunology will be as follows: Research Reports. These constitute the major category of communications. Each report consists of a detailed and complete description of the research problem, the experimental approach and the findings. It must provide new and significant knowledge and contain the information essential for verification of conclusions by other laboratories. Manuscripts are subject to detailed scrutiny by expert reviewers whose recommendations are the primary determinants of acceptability for publication. Groups of research reports as 'mini symposia' may also be organized by a Guest Editor, in agreement with the board of Regional Editors. Such reports will also be subject to critical review. It is anticipated that the publication of such invited groups of papers in selected areas may promote new openings in recently emerging fields and encourage individual contributions in these new areas. Short Communications. To provide rapid dissemination of timely and significant observation in molecular immunology, the journal will publish short communications in the form of a photographic reproduction of the original manuscript (2 or 4 pages). These manuscripts will also be evaluated by experts.
期刊描述简介:
Molecular Immunology is primarily devoted to the publication of immunological knowledge which can be delineated at the molecular level. Within this framework are included contributions concerned with the molecular analysis of the cellular components and processes which underlie the physiological behavior of cells involved in immune phenomena. Papers which merely describe new monoclonal antibodies and/or epitope mapping will no longer be accepted unless they have a direct relevance to the understanding of the immune system. The various forms of communications in Molecular Immunology will be as follows: Research Reports. These constitute the major category of communications. Each report consists of a detailed and complete description of the research problem, the experimental approach and the findings. It must provide new and significant knowledge and contain the information essential for verification of conclusions by other laboratories. Manuscripts are subject to detailed scrutiny by expert reviewers whose recommendations are the primary determinants of acceptability for publication. Groups of research reports as 'mini symposia' may also be organized by a Guest Editor, in agreement with the board of Regional Editors. Such reports will also be subject to critical review. It is anticipated that the publication of such invited groups of papers in selected areas may promote new openings in recently emerging fields and encourage individual contributions in these new areas. Short Communications. To provide rapid dissemination of timely and significant observation in molecular immunology, the journal will publish short communications in the form of a photographic reproduction of the original manuscript (2 or 4 pages). These manuscripts will also be evaluated by experts.
-
Exploring the genome-wide transcriptomic responses of Bulinus truncatus to Schistosoma haematobium infection: An important host-parasite system involved in the transmission of human urogenital schistosomiasis.
被引量:- 发表:1970
-
Piezo1 regulates TGF-β1 induced epithelial-mesenchymal transition in chronic rhinosinusitis with nasal polyps.
被引量:- 发表:1970
-
IL-17A activates JAK/STAT signaling to affect drug metabolizing enzymes and transporters in HepaRG cells.
被引量:- 发表:1970
-
Dendritic/antigen presenting cell mediated provision of T-cell receptor gamma delta (TCRγδ) expressing cells contributes to improving antileukemic reactions ex vivo.
被引量:- 发表:1970
-
VEGF165b mutant can be used as a protein carrier to form a chimeric tumor vaccine with Mucin1 peptide to elicit an anti-tumor response.
被引量:- 发表:1970